Loading...
Market
Reduction in Unauthorized Synthetic DNA Orders by 2024
5
Resolution / Starting Odds
Yes • 50%
No • 50%
Twist Bioscience annual report or official press release
Story
U.S. White House Policy Tightens Regulation on Synthetic DNA
May 8, 2024, 08:43 AM
The U.S. government is intensifying its efforts to regulate synthetic DNA, a move supported by industry leaders and biosecurity experts. A new White House policy aims to standardize the screening processes across companies like Twist Bioscience that produce and distribute synthetic DNA. This initiative seeks to prevent misuse by ensuring that providers verify both the sequences ordered and the credentials of those ordering them. Emily Leproust of Twist Bioscience welcomed the policy, emphasizing the ethical responsibility in promoting responsible research and rigorous screening of synthetic DNA.
View original story
Similar markets
High adoption by healthcare sector • 25%
High adoption by agricultural sector • 25%
Low adoption by healthcare sector • 25%
Low adoption by agricultural sector • 25%
Highly effective • 33%
Moderately effective • 33%
Not effective • 33%
EU introduces similar policies • 25%
China introduces similar policies • 25%
India introduces similar policies • 25%
No major regions introduce similar policies • 25%
No action • 33%
Warnings issued • 33%
Fines imposed • 34%
Reformulate supply chains • 33%
Seek exemptions • 33%
Challenge the Act legally • 34%
More firms investigated • 25%
Sanctions imposed • 25%
No significant actions • 25%
Other actions • 25%
0-5 • 25%
6-10 • 25%
11-20 • 25%
More than 20 • 25%